Peter Bruce-Clark describes backing transformative companies that some traditional venture capital firms pass on because at first glance the startup appears to be a charity rather than an industry changing unicorn. Social Impact Capital dives deep through its network of advisors to identify contrarian breakthrough technologies that have the chance to transform the world – from covalent drug therapies to DARPA backed IP that could cut deaths in automobile collisions by over 80%. With exits like OpenInvest and follow on investors like Andreessen Horowitz, Google Ventures, and Founders Fund, Silicon Valley is taking note of Social Impact Capital’s uncanny ability to identify seed stage companies driven by the 21st Century transition to an ESG driven economy that can represent outsized returns through structural revolutions in our society.